MSD Pharma (Singapore) Pte Ltd
MSD Pharma (Singapore) Pte Ltd
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole | Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer | Active, not recruiting | Phase 2 | 2026-07-14 | NCT05286437 |